|
|
Post by otherottawaguy on Mar 22, 2019 15:23:52 GMT -5
Here is what is being reported on Bloomberg (Symphony) as the "Institutional Sales" of Afrezza and I don't believe that these are counted in the weekly sales numbers:
2018
Jan 153k
Feb 116k
Mar 151.3k
Apr 172.4k
May 185.9k
Jun 139.2k
Jul 194.8k
Aug 194.0k
Sept 142.0k
Oct 195.2k
Nov 144.9k
Dec 191.0k
2018 Total 1.8M
2019
Jan 191.0k
Feb 279.0k *
*why the big jump: direct sales, discount program,...?
|
|
|
|
Post by otherottawaguy on Mar 22, 2019 15:24:39 GMT -5
Will be interested to see the Mar numbers.
|
|
|
|
Post by pguererro on Mar 22, 2019 15:34:58 GMT -5
Could also be territories where there is no sales rep
|
|
|
|
Post by mango on Mar 22, 2019 15:39:23 GMT -5
Here is what is being reported on Bloomberg (Symphony) as the "Institutional Sales" of Afrezza and I don't believe that these are counted in the weekly sales numbers: 2018Jan 153k Feb 116k Mar 151.3k Apr 172.4k May 185.9k Jun 139.2k Jul 194.8k Aug 194.0k Sept 142.0k Oct 195.2k Nov 144.9k Dec 191.0k 2018 Total 1.8M2019Jan 191.0k Feb 279.0k * *why the big jump: direct sales, discount program,...? Can you (or maybe anyone) explain what "Institutional Sales" means for those of us that do not know? 🙂 |
|
|
|
Post by parrerob on Mar 22, 2019 16:14:36 GMT -5
Ottowaguy.... Can you explain better also what are these numbers? I imagine they are monthly K dollars, correct?
So we are talking on around 50k per week.... That's quite nothing compared to 1M$....
|
|
|
|
Post by nylefty on Mar 22, 2019 16:18:53 GMT -5
Here is what is being reported on Bloomberg (Symphony) as the "Institutional Sales" of Afrezza and I don't believe that these are counted in the weekly sales numbers: (snipped)2018 Total 1.8M2019Jan 191.0k Feb 279.0k * *why the big jump: direct sales, discount program,...? Can you (or maybe anyone) explain what "Institutional Sales" means for those of us that do not know? 🙂 From the Symphony Health website:
Providing fast, flexible, and cost-effective measurement of the non-retail marketplace, NonRetailSourceâ„¢ incorporates indirect and direct drug sales into institutions including private and government hospitals, clinics, home healthcare providers, HMO captive pharmacies, mail-order pharmacies, and prisons.
|
|
|
|
Post by cedafuntennis on Mar 22, 2019 17:03:43 GMT -5
So if I read this correctly, this is over and above the other numbers we look at every month.
Regardless if that is true or not, the good thing is that is shows increased acceptance into hospitals and mail-orders. I doubt that prisons use Afrezza at this time or anytime soon... lol
|
|
|
|
Post by xanet on Mar 22, 2019 17:42:00 GMT -5
Pretty sure institutional sales are included in the numbers we already get. Still nice to see the breakdown. Source: Symphony Health |
|
|
|
Post by ltta on Mar 22, 2019 17:53:37 GMT -5
Here is what is being reported on Bloomberg (Symphony) as the "Institutional Sales" of Afrezza and I don't believe that these are counted in the weekly sales numbers: 2018Jan 153k Feb 116k Mar 151.3k Apr 172.4k May 185.9k Jun 139.2k Jul 194.8k Aug 194.0k Sept 142.0k Oct 195.2k Nov 144.9k Dec 191.0k 2018 Total 1.8M2019Jan 191.0k Feb 279.0k * *why the big jump: direct sales, discount program,...?
Could the big jump be the new Kaiser Program? They are an HMO and are included in Institutional Sales.
|
|
|
|
Post by sayhey24 on Mar 22, 2019 18:37:50 GMT -5
Maybe "mail-order pharmacies" Eagle Pharmacy? But thats a guess. www.insulinsavings.com/The Feb time matches the first full month of the program. |
|
|
|
Post by ltta on Mar 22, 2019 19:34:36 GMT -5
Maybe "mail-order pharmacies" Eagle Pharmacy? But thats a guess. www.insulinsavings.com/The Feb time matches the first full month of the program.
I vote for both... we'll know more in a few more months. Eagle will be 1,000 scripts max, unless Mannkind changes the plan.
EDIT --- I just remembered that MC said Eagle Pharmacy was not included in scripts..... so....
|
|
|
|
Post by MnkdWASmyRtrmntPlan on Mar 23, 2019 5:22:48 GMT -5
Maybe "mail-order pharmacies" Eagle Pharmacy? But thats a guess. www.insulinsavings.com/The Feb time matches the first full month of the program.
I vote for both... we'll know more in a few more months. Eagle will be 1,000 scripts max, unless Mannkind changes the plan.
EDIT --- I just remembered that MC said Eagle Pharmacy was not included in scripts..... so....
I think what Mike said is that Eagle sales are not included in "Symphony" scripts. But, they may be included in these "institutional" scripts. But, if they are, then this program is nowhere near 1000 scripts, and so, apparently not very successful. Unless, maybe they were slow to get started shipping the Rx's in Feb for some reason. In which case, March numbers should have a big jump. I hope otherottawaguy is able to update these numbers again with March numbers. That will be interesting. |
|
|
|
Post by mango on Mar 23, 2019 7:32:03 GMT -5
I still don't really understand what institutional sales is
|
|
|
|
Post by Clement on Mar 23, 2019 8:11:10 GMT -5
Maybe Tanner sales are included?
But I don't think that Tanner sales would count for many dollars.
(However, Tanner sales are extremely important for those Afrezza users overseas.)
|
|
|
|
Post by lakon on Mar 23, 2019 8:44:00 GMT -5
So if I read this correctly, this is over and above the other numbers we look at every month. Regardless if that is true or not, the good thing is that is shows increased acceptance into hospitals and mail-orders. I doubt that prisons use Afrezza at this time or anytime soon... lolPrisons would be an ideal market. There are a significant number of PWD and pre-diabetes in prison. There are obvious concerns about needle use and access. Afrezza would be ideally suited to help the patients while maintaining a safe environment for medical practitioners and others. From a marketing perspective, it is a highly controlled niche market that could easily be targeted and monopolized. Frankly, this idea came up before, and I'm not sure why MNKD has not assigned a "special" sales force to tackle it. A rather meager expense to dedicate someone to hold a conference for prison medical staff. MNKD could sell direct to boost volumes and profits while providing Afrezza at deep discounts for the publicity. They could use the anonymized data about the controlled population group in various ways to benefit everyone. It could be viewed as a kind of community service for both MNKD and prisoner volunteers.
|
|
